KeyRui Medical Secures Regulatory Approvals in Indonesia and Vietnam for Three Vascular Intervention Products, Accelerating Global Expansion

May 30, 2025 08:34 CST Updated 08:34

Cardiolink Science

Vascular Interventional Medical Device Developer

Expanding New Territories! Three of Our Vascular Intervention Products Receive Approval

Indonesia & VietnamMarketing Authorization！

Following the successful entry of its 8 products into the Latin American market, Cardiolink Science(Shenzhen)Medical Technology Development Co., Ltd. has once again achieved great success!Three vascular interventional products officially receive marketing approval in Vietnam and Indonesia.This breakthrough not only extends the company's deep cultivation achievements in the Latin American market but also marks a crucial step for China-produced vascular intervention solutions in Southeast Asia’s emerging markets. The global accessibility process is further accelerating, bringing more patients high-quality diagnostic and treatment options.

Deepening Emerging Markets, Empowering Regional Healthcare Upgrading

Southeast Asia is facing one of the world's most severe cardiovascular disease challenges. Taking Vietnam and Indonesia as examples, the total number of cardiovascular disease patients in the two countries has exceeded 60 million. However, there is a long-term reliance on imports for high-end interventional medical devices, and the uneven distribution of medical resources is particularly prominent.

The three vascular interventional products approved this time, with their excellent clinical innovation and outstanding cost-performance advantages, will precisely meet the local market needs, effectively alleviate the current shortage of mid-to-high-end medical devices, and provide better treatment options for patients in Southeast Asia.

Driven by Innovation, Building Global Competitiveness

As a leader in China's pan-vascular interventional field, the company has always been driven by "Therapy Insight" to build a product matrix covering the entire process of vascular intervention.

The product's excellent performance in quickly obtaining multi-country certifications worldwide is a result of the company's strict control over international standards and quality systems.From R&D to production, we take ISO 13485 as the cornerstone to ensure that every product meets the stringent requirements of major global markets.